Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Dawnrays Pharmaceutical Holdings Ltd    2348   KYG2687M1006

DAWNRAYS PHARMACEUTICAL HOLDINGS LTD

(2348)
My previous session
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
02/12/2019 02/13/2019 02/14/2019 02/15/2019 02/18/2019 Date
1.62 1.59 1.56 1.57 1.6 Last
651000 137000 147000 2580000 680252 Volume
0.00% -1.85% -1.89% +0.64% +1.91% Change
Company
Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business... 
Sector
Pharmaceuticals
Calendar
03/22Earnings Release
More about the company
Latest news on DAWNRAYS PHARMACEUTICAL HO
2018DAWNRAYS PHARMACEUTICAL HOLDINGS LTD : Ex-dividend day for interim dividend
FA
2018DAWNRAYS PHARMACEUTICAL HOLDINGS LTD : Ex-dividend day for extraordinary dividen..
FA
2018DAWNRAYS PHARMACEUTICAL HOLDINGS LTD : SPLIT: 2 of 1
FA
2018DAWNRAYS PHARMACEUTICAL : Pharma to consider special dividend payment
AQ
2018DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : Ex-dividend day for final dividend
FA
2018DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : annual earnings release
2017DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : Ex-dividend day for interim dividend
FA
2017DAWNRAYS PHARMACEUTICAL : Announcement of Interim Results for the six months end..
PU
2017DAWNRAYS PHARMACEUTICAL : Change in board lot size
PU
2017DAWNRAYS PHARMACEUTICAL (HOLDINGS) L : Ex-dividend day for final dividend
FA
More news
Analyst Recommendations on DAWNRAYS PHARMACEUTICAL HO
More recommendations
Sector news : Pharmaceuticals - NEC
02/17Cash-hoarding Japanese firms please investors as share buybacks hit record
RE
02/15BRISTOL MYERS SQUIBB : Starboard gauges Bristol-Myers shareholder support for Ce..
RE
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -2-
DJ
02/15WSJ TAX GUIDE 2019 : What Investors Need to Know -- Journal Report
DJ
More sector news : Pharmaceuticals - NEC
Chart DAWNRAYS PHARMACEUTICAL HOLDINGS LTD
Duration : Period :
Dawnrays Pharmaceutical Holdings Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAWNRAYS PHARMACEUTICAL HO
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Managers
NameTitle
Shao Jun Chen Chief Executive Officer & Executive Director
Kei Ling Li Chairman
Yung Lai Hung Executive Director
Hong Man Leung Non-Executive Director
Tung Sing Lo Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DAWNRAYS PHARMACEUTICAL HOLDINGS LTD6.08%318
JOHNSON & JOHNSON5.68%365 768
PFIZER-2.86%245 920
ROCHE HOLDING LTD.11.98%233 242
NOVARTIS7.19%228 685
MERCK AND COMPANY4.45%207 536